Dupixent (dupilumab) is a brand-name injection that’s prescribed for treating asthma. This article covers topics such as side effects, dosage, and how Dupixent works. Dupixent is available as a ...

Immunology superstar Dupixent, which first brought Regeneron and Sanofi together in 2007, has entered its megablockbuster era. But even as the billions pile up, Regeneron isn't entirely happy with ...

Bristol Myers Squibb has continued its ruthless cost-cutting push, dropping plans to commercialize a rival to Dupixent despite meeting its phase 3 goals and pumping the brakes on a would-be ...

Despite Eylea's market challenges, Dupixent's strong performance and future ... at least - and it may be the case that we will discover in 2025 that rumors of the death of Eylea have been "greatly ...

Despite lackluster sales of Eylea’s high-dose formulation and Sanofi-partnered Dupixent, Regeneron beat Q4 forecasts ... Sales of its blockbuster eye injection Eylea in the quarter dropped 11% year-on ...

A photo of a Bering Air Cessna 208B Grand Caravan in Nome, Alaska, the same type of plane that disappeared. (Quintin Soloviev via WikiCommons) ...

One primary reason is the strong performance and potential of Dupixent, which is expected to partially counterbalance the uncertainties surrounding Eylea. The expected growth in Dupixent’s ...

in some cases spreading across a majority of the body. It most commonly affects older people in the 60 to 80 age bracket. Dupixent (dupilumab) achieved a five-fold greater sustained remission rate ...

Authorities are frantically searching for an airplane carrying 10 people that went missing on its way to Nome, Alaska, according to officials. A Bering Air flight from Unalakleet to Nome failed to ...

Nacon revealed new accessories for the Nintendo Switch 2, including Joy-Con grips, chargers, and carrying cases. Nacon's range of accessories will be available at launch alongside the Nintendo ...

The CEO discussed the success of Dupixent and the remarkable achievement of over $13 billion in global sales in 2024, highlighting its commercial advantage and setting a milestone for Sanofi.